Correlation Between Eurobio Scientific and Carmat

Can any of the company-specific risk be diversified away by investing in both Eurobio Scientific and Carmat at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eurobio Scientific and Carmat into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eurobio Scientific SA and Carmat, you can compare the effects of market volatilities on Eurobio Scientific and Carmat and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eurobio Scientific with a short position of Carmat. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eurobio Scientific and Carmat.

Diversification Opportunities for Eurobio Scientific and Carmat

-0.06

Correlation Coefficient

Eurobio Scientific  Carmat

Good diversification

The 3 months correlation between Eurobio and Carmat is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Eurobio Scientific SA and Carmat in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmat and Eurobio Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eurobio Scientific SA are associated (or correlated) with Carmat. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmat has no effect on the direction of Eurobio Scientific i.e., Eurobio Scientific and Carmat go up and down completely randomly.

Pair Corralation between Eurobio Scientific and Carmat

Assuming the 90 days trading horizon Eurobio Scientific SA is expected to generate 0.42 times more return on investment than Carmat. However, Eurobio Scientific SA is 2.41 times less risky than Carmat. It trades about 0.07 of its potential returns per unit of risk. Carmat is currently generating about -0.06 per unit of risk. If you would invest  1,476  in Eurobio Scientific SA on September 24, 2024 and sell it today you would earn a total of  1,054  from holding Eurobio Scientific SA or generate 71.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eurobio Scientific SA  vs.  Carmat

Eurobio Scientific

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Eurobio Scientific SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable basic indicators, Eurobio Scientific is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Carmat

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Carmat has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Eurobio Scientific and Carmat

The main advantage of trading using opposite Eurobio Scientific and Carmat positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eurobio Scientific position performs unexpectedly, Carmat can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmat will offset losses from the drop in Carmat's long position.

The idea behind Eurobio Scientific SA and Carmat pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.